Emmessar Biotech & Nutrition Ltd. (BSE: 524768) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹14 Cr, it ranks #4,632 by market cap among the 6,197 Indian listed companies on FinBizNet, and #60 of 63 in Pharmaceuticals. At ₹26.36 (as of 16 Nov 2026), the share price is 21.0% below its 52-week high of ₹33.38 and 43.1% above its 52-week low of ₹18.42. The share price is down 12.8% over one year and up 7.9% over three months.
| Current Price | ₹26.36 |
|---|---|
| Market Cap | ₹14 Cr |
| BSE Code | 524768 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 32.4 |
| Return on Equity | 5.51% |
| Return on Assets | 1.31% |
| 52-Week Range | ₹18.42 – ₹33.38 |
| 1-Year Price Change | -12.8% |
| 3-Month Price Change | +7.9% |
| Beta (1Y) | 0.02 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.ebnl.org |
Delivery averaged 69.7% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Emmessar Biotech & Nutrition Limited, a healthcare company, provides healthcare and nutritional products in India and internationally. The company operates through Healthcare and Rent on Lease Land segments. It also offers CalmCream, a multi-functional skin cream; Calm Cream RESQ, a skin cream used for burns from sun, radiation, heat and chemicals; Cute-N-Comely, a cosmetic skin cream; MagiCream, a cream used for post-surgical scars; and Muscle Flex Gel, a gel used to relieve pain from aching muscles. In addition, the company offers vedaceuticals, an ayurveda disease curing medicine. Further, it provides healthcare products for dermatology, osteoporosis, anti-ageing, physical ailments, and burns, including radiation. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was incorporated in 1992 and is based in Mumbai, India.
1. Healthcare-This segment offers healthcare products. 2. Rent on Lease Land-This segment rents properties. 3. Others-0 4. Other Unallocable Expenditure (Net Off)-0
1. Rent on Leasehold Land-81.7% 2. Healthcare-18.3%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹56,531 Cr | 36.3 | 34.46% | ₹1,814 Cr | -8.1% |
| Emcure Pharmaceuticals Ltd | ₹42,344 Cr | 47.9 | 19.57% | ₹2,820 Cr | +73.3% |
| Ajanta Pharma Limited | ₹41,474 Cr | 39.4 | 25.39% | ₹1,794 Cr | +27.8% |
| Piramal Pharma Ltd | ₹32,600 Cr | n/m | -4.00% | ₹2,617 Cr | +22.8% |
| RUBICON RESEARCH LIMITED | ₹28,526 Cr | 112.3 | 19.14% | ₹576 Cr | +162.7% |
| Caplin Point Laboratories Ltdte | ₹18,155 Cr | 28.3 | 19.94% | ₹630 Cr | +23.6% |
| Pfizer Ltd. | ₹17,811 Cr | 24.5 | 17.16% | ₹727 Cr | -24.2% |
| Eris Lifesciences Ltd | ₹17,691 Cr | 28.3 | 18.07% | ₹892 Cr | -17.5% |
| Emmessar Biotech & Nutrition Ltd. | ₹14 Cr | 32.4 | 5.51% | — | -12.8% |
Listed by market capitalisation. Ratios are shown for context only.
Emmessar Biotech & Nutrition Ltd. is trading at ₹26.36, with a market capitalisation of ₹14 Cr.
Emmessar Biotech & Nutrition Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Emmessar Biotech & Nutrition Ltd. has a P/E of 32.4 and a return on equity of 5.51%.
Emmessar Biotech & Nutrition Ltd. is listed on the BSE under the scrip code 524768.
Emmessar Biotech & Nutrition Ltd.'s share price is down 12.8% over one year and up 7.9% over three months. Its 52-week range is ₹18.42 to ₹33.38.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.